Bakay, Umut, and Tuğba İzci Duran. 2025. “Real-World Effectiveness and Safety of Upadacitinib in Tumor Necrosis FactorInhibitor Refractory Axial Spondyloarthritis: 52-Week Outcomes from a Single-Center Cohort”. Archives of Rheumatology 40 (4):465-73. https://doi.org/10.5152/ArchRheumatol.2025.11098.